期刊文献+

吉西他滨通过上调miR-497抑制宫颈癌细胞的侵袭迁移 被引量:4

Gemcitabine inhibits invasion and migration of cervical cancer cells through upregulation of miR-497
下载PDF
导出
摘要 目的研究mi R-497在抑制宫颈癌侵袭迁移中的作用。方法将不同浓度梯度的吉西他滨作用于C33a细胞,MTT法检测细胞存活率计算IC50;给予宫颈癌细胞半数致死剂量的吉西他滨,Transwell及Wound Healing Assay检测吉西他滨对宫颈癌细胞侵袭迁移能力的影响。分别给予C33a细胞3.15mg/L及6.3mg/L的吉西他滨后,q RT-PCR检测mi R-497变化及Western blot检测已知mi R-497下游蛋白的变化。将mi R-497 mimic转入C33a细胞后,Transwell及Wound Healing Assay检测mi R-497对宫颈癌细胞侵袭迁移能力的影响。在给予C33a细胞吉西他滨的同时加入anti-mi R-497,即在mi R-497被抑制的情况下Western blot检测mi R-497下游与侵袭迁移相关的靶蛋白的变化,Transwell及Wound Healing Assay检测宫颈癌细胞侵袭迁移能力。结果吉西他滨可以有效地抑制宫颈癌细胞的侵袭迁移;吉西他滨促进宫颈癌细胞中mi R-497的表达;mi R-497可以抑制宫颈癌细胞的侵袭迁移;在mi R-49被阻遏的情况下,吉西他滨不能有效地抑制宫颈癌细胞的侵袭迁移。结论吉西他滨通过上调mi R-497的表达抑制宫颈癌细胞的侵袭迁移。 Objective To explore the role of mi R-497 in Gemcitabine caused dampened metastasis of cervical cancer. Methods IC50 values of Gemcitabine in C33 a was tested by MTT; After treated by Gemcitabine, the invasion and migration of C33 a were studied by Transwell and Wound Healing Assay. The mi R-497 levels was detected by q RT-PCR after C33 a was treated by Gemcitabine. When transfected by mi R-497 mimic, the invasion and migration of C33 A were studied by Transwell and Wound Healing Assay. Similarly, when treated by Gemcitabine and anti-mi R-497 simultaneously, the invasion and migration of C33 a were also studied by Transwell and Wound Healing Assay. Results Gemcitabine could inhibit the invasion and migration of C33a; mi R-497 was upregulated by Gemcitabine in C33a; mi R-497 could inhibit the invasion and migration of C33a; When mi R-497 could not be upregulated by Gemcitabine, the effects of Gemcitabine on invasion and migration of C33 a would be dampened. Conclusion Up-regulation of mi R-497 by Gemcitabine contributes to dampened metastasis of uterine cervical neoplasms.
作者 黄梦君 邹卿
出处 《解剖学研究》 CAS 2015年第4期262-267,共6页 Anatomy Research
关键词 吉西他滨 miR-497 宫颈癌 侵袭迁移 Gemcitabine miR-497 Cervical cancer Invasion and migration
  • 相关文献

参考文献27

  • 1Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden:Globocan 2000.Int J Cancer,2001,94(2):153-157.
  • 2Jemal A,Bray F,Center MM,et al.Global cancer statistics.CA Cancer J Clin,2011,61(2):69-75.
  • 3Rein DT,Kurbacher CM,Breidenbach M,et al.Weekly carboplatin and docetaxel for locally advanced primary and recurrent cervical cancer:a phase I study.Gynecol Oncol,2002,87(1):98-103.
  • 4Davidson JD,Ma L,Flagella M,et al.An increase in the expression of ribonucleotide reductase large subunit 1is associated with gemcitabine resistance in non-small cell lung cancer cell lines.Cancer Res,2004,64(11):3761-3765.
  • 5Bergman AM,Eijk PP,van Haperen VW R,et al.In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1as the major determinant.Cancer Res,2005,65(20):9510-9516.
  • 6Oguri T,Achiwa H,Sato S,et al.The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer:a role of ABCC5 in gemcitabine sensitivity.Mol Cancer Ther,2006,5(7):1800-1805.
  • 7Lai IL,Chou CC,Lai PT,et al.Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.Carcinogenesis,2014,35(10):2203-2209.
  • 8Xu JW,Wang TX,You L,et al.Insulin-like growth factor 1 receptor(IGF-1R)as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer.PLoS One,2014,9(3):e92847.
  • 9Luo M,Shen D,Zhou X,et al.MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulinlike growth factor 1 receptor.Surgery,2013,153(6):836-839.
  • 10韩继明,霍满鹏,慕明涛,刘俊俊,张静.miR-497靶向细胞周期蛋白E1抑制宫颈癌HeLa细胞的增殖[J].细胞与分子免疫学杂志,2014,30(6):597-600. 被引量:4

二级参考文献2

共引文献39

同被引文献34

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部